Literature DB >> 30730478

Laminin-511 Supplementation Enhances Stem Cell Localization With Suppression in the Decline of Cardiac Function in Acute Infarct Rats.

Nagako Sougawa1, Shigeru Miyagawa1, Satsuki Fukushima1, Junya Yokoyama1, Mutsunori Kitahara1, Akima Harada1, Noriko Mochizuki-Oda1, Ryoko Sato-Nishiuchi2, Kiyotoshi Sekiguchi2, Yoshiki Sawa1.   

Abstract

BACKGROUND: The extracellular matrix, in particular basement membrane components such as laminins (LMs), is essential for stem cell differentiation and self-renewal. LM511 and LM221 are the main extracellular matrix components of the epicardium, where stem cells were abundant. Here, we examined whether LMs affected the regeneration process by modulating stem cell activities.
METHODS: In vitro, adhesive, and proliferative activities of mesenchymal stem cells (MSCs) were evaluated on LM511 and LM221. To examine the effects of LMs in vivo, we established an acute myocardial infarction model by ligation of the proximal part of the left anterior descending artery at the height of the left atrial appendage and then placed atelocollagen sheets with or without LM511 and LM221 over the anterolateral surface of the left ventricular wall. Four or 8 weeks later, cardiac function, histology, and cytokine expressions were analyzed.
RESULTS: MSCs showed greater proliferation and adhesive properties on LM511 than on LM221. In vivo, at 4 weeks, isolectin B4-positive cells were significantly higher in the LM511-transplanted group than in the control group. Moreover, some isolectin B4-positive cells expressed both platelet-derived growth factor receptor α and CD90, suggesting that LM511 enhanced MSC recruitment and attachment at the implanted site. After 8 weeks, these cells were more abundant than at 4 weeks. Transplantation with LM511-conjugated sheets increased the expression of cardioprotective and angiogenic factors.
CONCLUSIONS: Transplantation with LM511-conjugated sheets enhanced MSC localization to the implantation site and modulated stem cells activities, leading to angiogenesis in acute myocardial infarction rat models.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30730478     DOI: 10.1097/TP.0000000000002653

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Can't handle the stress? Mechanobiology and disease.

Authors:  Noam Zuela-Sopilniak; Jan Lammerding
Journal:  Trends Mol Med       Date:  2022-06-15       Impact factor: 15.272

Review 2.  Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior.

Authors:  Vigneshwari Easwar Kumar; Roshni Nambiar; Cristabelle De Souza; Audrey Nguyen; Jeremy Chien; Kit S Lam
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

3.  Combined administration of laminin-221 and prostacyclin agonist enhances endogenous cardiac repair in an acute infarct rat heart.

Authors:  Nagako Sougawa; Shigeru Miyagawa; Takuji Kawamura; Ryohei Matsuura; Akima Harada; Yoshiki Sakai; Noriko Mochizuki-Oda; Ryoko Sato-Nishiuchi; Kiyotoshi Sekiguchi; Yoshiki Sawa
Journal:  Sci Rep       Date:  2021-11-15       Impact factor: 4.379

4.  Tailorable Hydrogel Improves Retention and Cardioprotection of Intramyocardial Transplanted Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice.

Authors:  Youhu Chen; Congye Li; Chengxiang Li; Jiangwei Chen; Yan Li; Huaning Xie; Chen Lin; Miaomiao Fan; Yongzhen Guo; Erhe Gao; Wenjun Yan; Ling Tao
Journal:  J Am Heart Assoc       Date:  2020-01-18       Impact factor: 5.501

5.  Laminin-221 Enhances Therapeutic Effects of Human-Induced Pluripotent Stem Cell-Derived 3-Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy Model.

Authors:  Takaaki Samura; Shigeru Miyagawa; Takuji Kawamura; Satsuki Fukushima; Jun-Ya Yokoyama; Maki Takeda; Akima Harada; Fumiya Ohashi; Ryoko Sato-Nishiuchi; Toshihiko Toyofuku; Koichi Toda; Kiyotoshi Sekiguchi; Yoshiki Sawa
Journal:  J Am Heart Assoc       Date:  2020-08-12       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.